Ayala Pharmaceuticals Inc
β Verified ManufacturerPharmaceuticals β’ π Wilmington, DE β’ Est. 2017
About
Clinical-stage oncology company focused on developing and commercializing small molecule therapeutics for people living with rare tumors and aggressive cancers. Lead candidates include oral gamma secretase inhibitor AL102 for desmoid tumors, and intravenous gamma secretase inhibitor AL101 for adenoid cystic carcinoma.
Specialties
Manufacturing Capabilities
Processes
Location
Wilmington, DE